INTRODUCTION There is conflicting evidence and practice regarding the use of the non-nucleoside reverse transcriptase inhibitors (NNRTI) efavirenz (EFV) and nevirapine (NVP) in first...
Ford NP, Shubber Z, Saranchuk P, Pathai S, Durier N, et al.
2013-07-29 • Clinical Infectious Diseases
2013-07-29 • Clinical Infectious Diseases
BACKGROUND Cytomegalovirus (CMV) is a late-stage opportunistic infection in people living with human immunodeficiency virus (HIV)/AIDS. Lack of ophthalmological diagnostic skills, la...
Ford NP, Scourse R, Lemoine M, Hutin Y, Bulterys M, et al.
2018-10-01 • Hepatology Communications
2018-10-01 • Hepatology Communications
Successful treatment outcomes for chronic hepatitis B virus (HBV) infection requires high levels of adherence to treatment. We searched three databases and abstracts from two conferences...
Ford NP, Mofenson L, Shubber Z, Calmy A, Andrieux-Meyer I, et al.
2011-11-28 • AIDS
2011-11-28 • AIDS
INTRODUCTION Primate studies and some observational human data have raised concern regarding an association of first-trimester efavirenz exposure with central nervous system congenit...
